Samrat Pharmachem Limited

BSE:530125 Stock Report

Market Cap: ₹1.2b

Samrat Pharmachem Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 530125?
Owner TypeNumber of SharesOwnership Percentage
Institutions125,4964.06%
Private Companies140,4444.55%
General Public1,141,54536.9%
Individual Insiders1,682,21554.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 63.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Lalit Mehta
431,498₹166.3m0%no data
12.4%
Rajesh Mehta
383,542₹147.8m0%no data
5.67%
Premal Mehta
175,281₹67.6m0%no data
4.5%
Kaushal Mehta
139,065₹53.6m0%no data
3.86%
Jaya Mehta
119,300₹46.0m0%no data
3.27%
S. Sangeetha
101,000₹38.9m0%no data
3.24%
Lloyds Securities Overseas Ltd
100,000₹38.5m0%no data
2.66%
Rupal Mehta
82,182₹31.7m0%no data
2.15%
Falguni Mehta
66,400₹25.6m0%no data
2.11%
Golechha Global Finance Limited, Asset Management Arm
65,240₹25.1m0%no data
1.71%
Megh Mehta
52,882₹20.4m13.4%no data
1.64%
Kalpana Mehta
50,600₹19.5m0%no data
1.53%
Alert Consultants & Credit Private Limited, Asset Management Arm
47,169₹18.2m0%no data
1.31%
Anshul Specialty Molecules Private Limited
40,444₹15.6m0%no data
1.13%
Sharad Shah
35,000₹13.5m0%no data
0.42%
Rajasthan Global Securities Limited, Asset Management Arm
13,087₹5.0m0%0.03%
0.4%
Divyanshu Kantol
12,500₹4.8m0%no data
0.38%
Maitri Mehta
11,744₹4.5m42.5%no data
0.36%
Ponguleti Reddy
10,971₹4.2m0%no data
0.32%
Rajendra Sanghavi
10,000₹3.9m0%no data
0.0065%
Samir Kothary
200₹77.0k0%no data
0.00081%
Mahendra Pipalia
25₹9.6k0%no data
0.00081%
Renu Dharod
25₹9.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 22:48
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Samrat Pharmachem Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution